BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27308511)

  • 1. The ubiquitin-proteasome system and activation of NF-κB: involvement of the ubiquitin ligase KPC1 in p105 processing and tumor suppression.
    Kravtsova-Ivantsiv Y; Ciechanover A
    Mol Cell Oncol; 2015; 2(4):e1054552. PubMed ID: 27308511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A short binding site in the KPC1 ubiquitin ligase mediates processing of NF-κB1 p105 to p50: A potential for a tumor-suppressive PROTAC.
    Goldhirsh G; Kravtsova-Ivantsiv Y; Satish G; Ziv T; Brik A; Ciechanover A
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34873064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growth.
    Kravtsova-Ivantsiv Y; Shomer I; Cohen-Kaplan V; Snijder B; Superti-Furga G; Gonen H; Sommer T; Ziv T; Admon A; Naroditsky I; Jbara M; Brik A; Pikarsky E; Kwon YT; Doweck I; Ciechanover A
    Cell; 2015 Apr; 161(2):333-47. PubMed ID: 25860612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NF-ĸB p50 subunit generated by KPC1-mediated ubiquitination and limited proteasomal processing, suppresses tumor growth.
    Kravtsova-Ivantsiv Y; Goldhirsh G; Tomuleasa C; Pikarsky E; Ciechanover A
    Cancer Cell Int; 2023 Apr; 23(1):67. PubMed ID: 37055826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p105 NF-ĸB precursor is a pseudo substrate of the ubiquitin ligase FBXO7, and its binding to the ligase stabilizes it and results in stimulated cell proliferation.
    Udasin RG; Gottfried Y; Fabre B; Bercovich B; Ziv T; Ciechanover A
    Biochem Biophys Res Commun; 2021 Jun; 558():224-230. PubMed ID: 32933748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A20 inhibits both the degradation and limited processing of the NF-κB p105 precursor: A novel additional layer to its regulator role.
    Lapid D; Lahav-Baratz S; Cohen S
    Biochem Biophys Res Commun; 2017 Nov; 493(1):52-57. PubMed ID: 28923245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Tumor Suppressor Functions of Ubiquitin Ligase KPC1: From Cell-Cycle Control to NF-κB Regulator.
    Gulei D; Drula R; Ghiaur G; Buzoianu AD; Kravtsova-Ivantsiv Y; Tomuleasa C; Ciechanover A
    Cancer Res; 2023 Jun; 83(11):1762-1767. PubMed ID: 36880841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess of the NF-ĸB p50 subunit generated by the ubiquitin ligase KPC1 suppresses tumors via PD-L1- and chemokines-mediated mechanisms.
    Kravtsova-Ivantsiv Y; Goldhirsh G; Ivantsiv A; Ben Itzhak O; Kwon YT; Pikarsky E; Ciechanover A
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29823-29831. PubMed ID: 33168738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The A-to-I editing of KPC1 promotes intrahepatic cholangiocarcinoma by attenuating proteasomal processing of NF-κB1 p105 to p50.
    Gao C; Zhou G; Shi J; Shi P; Jin L; Li Y; Wang X; Liao S; Yan H; Wu J; Lu Y; Zhai Y; Zhang J; Zhang H; Zhang H; Yang C; Cao P; Cheng S; Zhou G
    J Exp Clin Cancer Res; 2022 Dec; 41(1):338. PubMed ID: 36476255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFKB1: a suppressor of inflammation, ageing and cancer.
    Cartwright T; Perkins ND; L Wilson C
    FEBS J; 2016 May; 283(10):1812-22. PubMed ID: 26663363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma.
    Iida Y; Ciechanover A; Marzese DM; Hata K; Bustos M; Ono S; Wang J; Salomon MP; Tran K; Lam S; Hsu S; Nelson N; Kravtsova-Ivantsiv Y; Mills GB; Davies MA; Hoon DSB
    Clin Cancer Res; 2017 Aug; 23(16):4831-4842. PubMed ID: 28389511
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural motifs involved in ubiquitin-mediated processing of the NF-kappaB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domain.
    Orian A; Schwartz AL; Israël A; Whiteside S; Kahana C; Ciechanover A
    Mol Cell Biol; 1999 May; 19(5):3664-73. PubMed ID: 10207090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary study on the inhibitory effect of tumor suppressor gene KPC1 on the proliferation in gastric carcinoma cell.
    Zhou M; Qu CY; Ding WJ; Cai XL; Shen YJ; Chen YW; Xu LM
    Ann Transl Med; 2020 Mar; 8(6):343. PubMed ID: 32355787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of ubiquitin-mediated, limited processing of the NF-kappaB1 precursor protein p105.
    Ciechanover A; Gonen H; Bercovich B; Cohen S; Fajerman I; Israël A; Mercurio F; Kahana C; Schwartz AL; Iwai K; Orian A
    Biochimie; 2001; 83(3-4):341-9. PubMed ID: 11295495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-kappaB precursor.
    Kravtsova-Ivantsiv Y; Cohen S; Ciechanover A
    Mol Cell; 2009 Feb; 33(4):496-504. PubMed ID: 19250910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin ligase TRUSS augments the expression of interleukin-10 via proteasomal processing of NF-κB1/p105 to NF-κB/p50.
    Jamal A; Husein A; Bihari C; Kumar V
    Cell Signal; 2020 Nov; 75():109766. PubMed ID: 32889079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing of p105 is inhibited by docking of p50 active subunits to the ankyrin repeat domain, and inhibition is alleviated by signaling via the carboxyl-terminal phosphorylation/ ubiquitin-ligase binding domain.
    Cohen S; Orian A; Ciechanover A
    J Biol Chem; 2001 Jul; 276(29):26769-76. PubMed ID: 11350967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism.
    Guégan JP; Pollet J; Ginestier C; Charafe-Jauffret E; Peter ME; Legembre P
    iScience; 2021 Dec; 24(12):103538. PubMed ID: 34917906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.
    Heissmeyer V; Krappmann D; Hatada EN; Scheidereit C
    Mol Cell Biol; 2001 Feb; 21(4):1024-35. PubMed ID: 11158290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.
    Heissmeyer V; Krappmann D; Wulczyn FG; Scheidereit C
    EMBO J; 1999 Sep; 18(17):4766-78. PubMed ID: 10469655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.